Your browser doesn't support javascript.
loading
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
Tan, Carlyn Rose; Derkach, Andriy; Nemirovsky, David; Ciardiello, Amanda; Diamond, Benjamin; Hultcrantz, Malin; Hassoun, Hani; Mailankody, Sham; Shah, Urvi; Maclachlan, Kylee; Patel, Dhwani; Lahoud, Oscar; Landau, Heather; Chung, David; Shah, Gunjan; Scordo, Michael; Giralt, Sergio; Lesokhin, Alexander; Usmani, Saad; Landgren, Ola; Korde, Neha.
Afiliação
  • Tan CR; Memorial Sloan Kettering Cancer Center.
  • Derkach A; MSKCC.
  • Nemirovsky D; Memorial Sloan Kettering Cancer Center.
  • Ciardiello A; Memorial Sloan Kettering Cancer Center.
  • Diamond B; University of Miami.
  • Hultcrantz M; Memorial Sloan Kettering Cancer Center.
  • Hassoun H; Memorial Sloan Kettering Cancer Center.
  • Mailankody S; Memorial Sloan Kettering Cancer Center.
  • Shah U; Memorial Sloan Kettering Cancer Center.
  • Maclachlan K; Memorial Sloan Kettering Cancer Center.
  • Patel D; Memorial Sloan Kettering Cancer Center.
  • Lahoud O; Memorial Sloan Kettering Cancer Center.
  • Landau H; Memorial Sloan-Kettering Cancer Center.
  • Chung D; Memorial Sloan Kettering Cancer Center.
  • Shah G; MSKCC.
  • Scordo M; Memorial Sloan Kettering Cancer Center.
  • Giralt S; Memorial Sloan-Kettering Cancer Center.
  • Lesokhin A; Memorial Sloan Kettering Cancer Center.
  • Usmani S; Memorial Sloan Kettering Cancer Center.
  • Landgren O; Sylvester Comprehensive Cancer Center, University of Miami.
  • Korde N; Memorial Sloan Kettering Cancer Center.
Res Sq ; 2023 Feb 24.
Article em En | MEDLINE | ID: mdl-36865246

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article